Spectronaut® 19 offers significant improvements in identifications, candidate discovery, scalability for large-scale analysis, and support for novel workflows Novel TrueDiscovery® P2 Plasma Enrichment ...

The leading software solution for DIA proteomics is compatible with MS instruments from all major vendors, including Bruker Daltonics, and Thermo Fisher Scientific SCHLIEREN, Switzerland — Biognosys, ...

ZURICH, Switzerland and CANCUN, Mexico, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Biognosys, a leader in next-generation proteomics solutions for life science research and drug development, will launch ...

Spectronaut® 18 makes DIA proteomics projects more efficient and scalable than ever for all mass spectrometry instrument types Novel research with TrueDiscovery™ and TrueTarget™ demonstrates the ...

Biognosys AG has announced the second release of its Spectronaut™ software for analysis of Hyper Reaction Monitoring (HRM) data. HRM is a targeted proteomics technology that enables reproducible and ...

ZURICH and BOSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Biognosys, a global leader in mass spectrometry-based proteomics solutions, announces the launch of Spectronaut ® 20 and SpectroMine ™ 5 at the ASMS ...

Data-independent acquisition (DIA) has become the method of choice for large-scale discovery proteomics. Its application for single-cell analysis promises to be more sensitive, robust, and ...

This article provides a summary of Biognosys’ Spectronaut 15 Launch Seminar, featuring lead developer Oliver Bernhardt from Biognosys and Andreas-David Brunner from Matthias Mann’s lab at the Max ...

Highlights include the launch of Spectronaut® 16, which has undergone one of its most transformative upgrades to date, and innovations to Biognosys’ proprietary TrueTarget™ and TrueDiscovery™ ...

SCHLIEREN, Switzerland--(BUSINESS WIRE)--Biognosys, a leader in next-generation proteomics solutions for life sciences research and development, announced today the launch of Spectronaut 15. The ...